Develops vaccines and diagnostic products for immunological treatments.
Jun 2026Revenue $7.68K/yrExpenses $193K/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will Fuse Group Holding be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $7.68K and expenses $193K.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Sep 2025 | $45.9K | $324K | −$278K |
| Sep 2024 | $332K | $365K | −$33.4K |
| Sep 2023 | $0.00 | $455K | −$455K |
| Sep 2022 | $200K | $634K | −$434K |
| Sep 2021 | $700K | $1.77M | −$1.07M |
| Sep 2020 | $750K | $795K | −$45.3K |
| Sep 2019 | $1.22M | $1.29M | −$77.8K |
| Sep 2018 | $0.00 | $4.10M | −$4.10M |
| Sep 2017 | $0.00 | $1.52M | −$1.52M |
| Sep 2016 | $25.2K | $68.3K | −$43.1K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.